Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Vector Science and Therapeutics's PB Ratio or its related term are showing as below:
TSXV:PAIN'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 9.15
Current: 8.75
During the past 2 years, Vector Science and Therapeutics's highest PB Ratio was 9.15. The lowest was 0.00. And the median was 0.00.
TSXV:PAIN's PB Ratio is ranked worse than 90.46% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.005
vs TSXV:PAIN: 8.75
Back to Basics: PB Ratio
Vector Science and Therapeutics (TSXV:PAIN) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Vector Science and Therapeutics PB Ratio Related Terms
Vector Science and Therapeutics PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vector Science and Therapeutics PB Ratio Chart
Vector Science and Therapeutics Annual Data
Trend
Aug24
Aug25
PB Ratio
0.00
0.00
Vector Science and Therapeutics Quarterly Data
Aug24
Nov24
Aug25
Nov25
Feb26
PB Ratio
0.00
0.00
0.00
0.00
0.00
TSXV:PAIN vs ABT, SYK, MDT: PB Ratio Comparison
For the Medical Devices subindustry, Vector Science and Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vector Science and Therapeutics PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vector Science and Therapeutics's PB Ratio distribution charts can be found below:
* The bar in red indicates where Vector Science and Therapeutics's PB Ratio falls into.
Vector Science and Therapeutics PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Vector Science and Therapeutics (TSXV:PAIN) has a PB Ratio of 8.76 as of Jul. 21, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Vector Science and Therapeutics and its competitors. According to the industry distribution chart, Vector Science and Therapeutics ranks #711 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 90.5%.
Is Vector Science and Therapeutics' PB Ratio too high?
Vector Science and Therapeutics' current PB Ratio is 8.76. The Medical Devices & Instruments industry median PB Ratio is 2.01. Vector Science and Therapeutics' value of 8.76 is 336.9% above this industry median. Based on the distribution chart, Vector Science and Therapeutics ranks #711 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Vector Science and Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Vector Science and Therapeutics' PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vector Science and Therapeutics ranks #711 out of 786 companies for PB Ratio. This places Vector Science and Therapeutics in the lower half of its industry. The industry median PB Ratio is 2.01. Vector Science and Therapeutics' value of 8.76 is 336.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.01, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vector Science and Therapeutics's current PB Ratio of 8.76 is 336.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Vector Science and Therapeutics and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vector Science and Therapeutics's current PB Ratio is 8.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vector Science and Therapeutics stock overvalued right now?
Vector Science and Therapeutics (TSXV:PAIN) has a current PB Ratio of 8.76. The current PB Ratio is 8.76 and 336.9% above the Medical Devices & Instruments industry median of 2.01. Vector Science and Therapeutics' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Vector Science and Therapeutics (TSXV:PAIN), the current PB Ratio is 8.76 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vector Science and Therapeutics Business Description
Vector Science and Therapeutics Corp develops novel biomechanical devices and active transdermal drug and peptide delivery platforms to equip clinicians with non-systemic, localized interventions targeting a broad cross-section of diseases and conditions where systemic delivery of interventions compromises the therapeutic effect or introduces unacceptable harm.
14GF Score
Get the complete analysis for TSXV:PAIN
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PAIN has been successfully added to your 
